Literature DB >> 22554913

Skeletal metastases - the role of the orthopaedic and spinal surgeon.

Nicholas Eastley1, Martyn Newey, Robert U Ashford.   

Abstract

Developments in oncological and medical therapies mean that life expectancy of patients with metastatic bone disease (MBD) is often measured in years. Complications of MBD may dramatically and irreversibly affect patient quality of life, making the careful assessment and appropriate management of these patients essential. The roles of orthopaedic and spinal surgeons in MBD generally fall into one of four categories: diagnostic, the prophylactic fixation of metastatic deposits at risk of impending fracture (preventative surgery), the stabilisation or reconstruction of bones affected by pathological fractures (reactive surgery), or the decompression and stabilisation of the vertebral column, spinal cord, and nerve roots. Several key principals should be adhered to whenever operating on skeletal metastases. Discussions should be held early with an appropriate multi-disciplinary team prior to intervention. Detailed pre-assessment is essential to gauge a patient's suitability for surgery - recovery from elective surgery must be shorter than the anticipated survival. Staging and biopsies provide prognostic information. Primary bone tumours must be ruled out in the case of a solitary bone lesion to avoid inappropriate intervention. Prophylactic surgical fixation of a lesion prior to a pathological fracture reduces morbidity and length of hospital stay. Regardless of a lesion or pathological fracture's location, all regions of the affected bone must be addressed, to reduce the risk of subsequent fracture. Surgical implants should allow full weight bearing or return to function immediately. Post-operative radiotherapy should be utilised in all cases to minimise disease progression. Spinal surgery should be considered for those with spinal pain due to potentially reversible spinal instability or neurological compromise. The opinion of a spinal surgeon should be sought early, as delays in referral directly correlate to worse functional recovery following intervention. Patients who suffer a slowly progressive deficit, present within hours of complete neurological deficit, or have compression caused by bone alone are those most likely to benefit from surgery. Back pain in the presence of MBD should be regarded as impending spinal cord compression, and investigated urgently to allow intervention prior to the development of neurological compromise.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22554913     DOI: 10.1016/j.suronc.2012.04.001

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  25 in total

1.  Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma.

Authors:  Montserrat Ayala-Ramirez; J Lynn Palmer; Marie-Claude Hofmann; Maxine de la Cruz; Bryan S Moon; Steven G Waguespack; Mouhammed Amir Habra; Camilo Jimenez
Journal:  J Clin Endocrinol Metab       Date:  2013-02-22       Impact factor: 5.958

Review 2.  The evolution of cancer surgery and future perspectives.

Authors:  Lynda Wyld; Riccardo A Audisio; Graeme J Poston
Journal:  Nat Rev Clin Oncol       Date:  2014-11-11       Impact factor: 66.675

Review 3.  A Focused Review of Safety Considerations in Cancer Rehabilitation.

Authors:  Susan Maltser; Adrian Cristian; Julie K Silver; G Stephen Morris; Nicole L Stout
Journal:  PM R       Date:  2017-09       Impact factor: 2.298

4.  Should the Use of Biologic Agents in Patients With Renal and Lung Cancer Affect Our Surgical Management of Femoral Metastases?

Authors:  Christina J Gutowski; Benjamin Zmistowski; Nicola Fabbri; Patrick J Boland; John H Healey
Journal:  Clin Orthop Relat Res       Date:  2019-04       Impact factor: 4.176

Review 5.  Fear of impending fractures: when to refer? A case-based review.

Authors:  Caroline Kronisch; Federico Balagué; Jean Dudler
Journal:  Clin Rheumatol       Date:  2014-01-03       Impact factor: 2.980

6.  The Metastatic Spine Disease Multidisciplinary Working Group Algorithms.

Authors:  Adam N Wallace; Clifford G Robinson; Jeffrey Meyer; Nam D Tran; Afshin Gangi; Matthew R Callstrom; Samuel T Chao; Brian A Van Tine; Jonathan M Morris; Brian M Bruel; Jeremiah Long; Robert D Timmerman; Jacob M Buchowski; Jack W Jennings
Journal:  Oncologist       Date:  2015-09-09

7.  External Validation and Optimization of the SPRING Model for Prediction of Survival After Surgical Treatment of Bone Metastases of the Extremities.

Authors:  Michala Skovlund Sørensen; Thomas Alexander Gerds; Klaus Hindsø; Michael Mørk Petersen
Journal:  Clin Orthop Relat Res       Date:  2018-08       Impact factor: 4.176

8.  CT-based Structural Rigidity Analysis Is More Accurate Than Mirels Scoring for Fracture Prediction in Metastatic Femoral Lesions.

Authors:  Timothy A Damron; Ara Nazarian; Vahid Entezari; Carlos Brown; William Grant; Nathan Calderon; David Zurakowski; Richard M Terek; Megan E Anderson; Edward Y Cheng; Albert J Aboulafia; Mark C Gebhardt; Brian D Snyder
Journal:  Clin Orthop Relat Res       Date:  2016-03       Impact factor: 4.176

9.  Preoperative prediction for regaining ambulatory ability in paretic non-ambulatory patients with metastatic spinal cord compression.

Authors:  M Ohashi; T Hirano; K Watanabe; K Katsumi; H Shoji; A Sano; H Tashi; I Takahashi; M Wakasugi; Y Shibuya; N Endo
Journal:  Spinal Cord       Date:  2016-10-18       Impact factor: 2.772

10.  Evaluation of prognostic scoring systems for bone metastases using single-center data.

Authors:  Hirofumi Shimada; Takao Setoguchi; Shunsuke Nakamura; Masahiro Yokouchi; Yasuhiro Ishidou; Hiroyuki Tominaga; Ichiro Kawamura; Satoshi Nagano; Setsuro Komiya
Journal:  Mol Clin Oncol       Date:  2015-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.